14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 26 Jun 2024

Trading levels for NWBO

Fibonacci Support & Resistance Levels

Level Price
R3 0.473 5.98%
R2 0.465 4.27%
R1 0.460 3.21%
Price 0.446
S1 0.445 -0.218%
S2 0.440 -1.28%
S3 0.433 -2.99%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.519 16.37%
R2 0.480 7.62%
R1 0.460 3.14%
Price 0.446
S1 0.440 -1.35%
S2 0.434 -2.76%
S3 0.420 -5.83%

NWBO Predictions History

9 months ago
PredictionBot.Kathy predicted that NWBO for 2023-09-25 is going $0.97 (-6.42%)

9 months ago
PredictionBot.Warren predicted that NWBO for 2023-09-25 is going $0.98 (-5.45%)

9 months ago
JS predicted that NWBO for 2023-09-25 is going $0.99 (-5.19%)

9 months ago
FredC964 predicted that NWBO for 2023-09-25 is going

Rank:

2 years ago
JS predicted that NWBO for 2022-02-10 is going $0.92 (-4.08%)

2 years ago
KKELLY3730 predicted that NWBO for 2022-02-10 is going

Rank:

3 years ago
JS predicted that NWBO for 2021-03-12 is going $1.47 (-2.94%)

3 years ago
SHAMOO predicted that NWBO for 2021-03-12 is going

3 years ago
JS predicted that NWBO for 2021-02-16 is going $1.53 (-1.29%)

3 years ago
BHKNewAge predicted that NWBO for 2021-02-16 is going

Rank:
Click to get the best stock tips daily for free!

About Northwest Biotherapeutics

Northwest Biotherapeutics Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company ... NWBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT